The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of the bone-targeting cytotoxic conjugate, etidronate-cytosine arabinoside (MBC-11), in cancer patients with bone metastases.
 
Shawn Zinnen
Employment - MBC Pharma
Leadership - MBC Pharma; Osteros Biomedica
Stock and Other Ownership Interests - MBC Pharma; Osteros Biomedica
Research Funding - MBC Pharma
Patents, Royalties, Other Intellectual Property - MBC Pharma; Osteros Biomedica
Travel, Accommodations, Expenses - MBC Pharma
 
Eric Keith Rowinsky
Employment - Rgenix; Stemline Therapeutics
Leadership - BIND Therapeutics; Biogen; Fortress Biotech; Navidea; Rgenix; Stemline Therapeutics
Stock and Other Ownership Interests - BIND Therapeutics; Biogen; Fortress Biotech; Navidea; Rgenix; Stemline Therapeutics
Honoraria - Osteros Biomedica
Consulting or Advisory Role - BioXCell; Mesoblast; Mitra Biotech; Osteros Biomedica
 
Alexander Alexandrov
Employment - Myr GmbH
Stock and Other Ownership Interests - Myr GmbH
Patents, Royalties, Other Intellectual Property - Myr GmbH
 
Larisa Plekhova
Employment - Osteros Biomedica
 
Marina Roudas
Consulting or Advisory Role - Osteros Biomedica; Siemens Healthcare Diagnostics
Research Funding - Siemens Healthcare Diagnostics
Travel, Accommodations, Expenses - Siemens Healthcare Diagnostics
 
Alexander Karpeisky
Employment - MBC Pharma
Leadership - MBC Pharma; Osteros Biomedica
Stock and Other Ownership Interests - MBC Pharma; Osteros Biomedica
Consulting or Advisory Role - Osteros Biomedica
Research Funding - MBC Pharma